Importance of Echocardiography and Clinical “Red Flags” in Guiding Genetic Screening for Fabry Disease

Importance of Echocardiography and Clinical “Red Flags” in Guiding Genetic Screening for Fabry Disease

IntroductionAim of this study was to evaluate, in a metropolitan area not already explored, the prevalence of Anderson–Fabry disease, by genetic screening, in patients with echocardiographic evidence of left ventricular hypertrophy (LVH) of unknown origin and “clinical red flags”.MethodsFrom August...

Full description

Bibliographic Details
Main Authors: Rodolfo Citro, Costantina Prota, Donatella Ferraioli, Giuseppe Iuliano, Michele Bellino, Ilaria Radano, Angelo Silverio, Serena Migliarino, Maria Vincenza Polito, Artemisia Ruggiero, Rosa Napoletano, Vincenzo Bellizzi, Michele Ciccarelli, Gennaro Galasso, Carmine Vecchione
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Fabry disease
myocardial hypertrophy
echocardiography
screening
genetic
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.838200/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.838200/full

Similar Items